Cargando…

Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β

Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Kathrin, Jäger, Christian, Geissler, Stefanie, Schlenzig, Dagmar, Buchholz, Mirko, Ramsbeck, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870012/
https://www.ncbi.nlm.nih.gov/pubmed/36661029
http://dx.doi.org/10.1080/14756366.2023.2165648
_version_ 1784876886235545600
author Tan, Kathrin
Jäger, Christian
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Ramsbeck, Daniel
author_facet Tan, Kathrin
Jäger, Christian
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Ramsbeck, Daniel
author_sort Tan, Kathrin
collection PubMed
description Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still requires highly potent and selective inhibitors as chemical probes to elucidate their role in pathophysiology. Albeit highly selective inhibitors of meprin β have already been reported, only inhibitors of meprin α with modest activity or selectivity are known. Starting from recently reported heteroaromatic scaffolds, the aim of this study was the optimisation of meprin α and/or meprin β inhibition while keeping the favourable off-target inhibition profile over other metalloproteases. We report potent pan-meprin inhibitors as well as highly active inhibitors of meprin α with superior selectivity over meprin β. The latter are suitable to serve as chemical probes and enable further target validation.
format Online
Article
Text
id pubmed-9870012
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-98700122023-01-24 Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β Tan, Kathrin Jäger, Christian Geissler, Stefanie Schlenzig, Dagmar Buchholz, Mirko Ramsbeck, Daniel J Enzyme Inhib Med Chem Research Paper Targeting metalloproteinases has been in the focus of drug design for a long time. However, meprin α and β emerged as potential drug targets just recently and are linked to several diseases with different pathological background. Nevertheless, the validation of meprins as suitable drug targets still requires highly potent and selective inhibitors as chemical probes to elucidate their role in pathophysiology. Albeit highly selective inhibitors of meprin β have already been reported, only inhibitors of meprin α with modest activity or selectivity are known. Starting from recently reported heteroaromatic scaffolds, the aim of this study was the optimisation of meprin α and/or meprin β inhibition while keeping the favourable off-target inhibition profile over other metalloproteases. We report potent pan-meprin inhibitors as well as highly active inhibitors of meprin α with superior selectivity over meprin β. The latter are suitable to serve as chemical probes and enable further target validation. Taylor & Francis 2023-01-20 /pmc/articles/PMC9870012/ /pubmed/36661029 http://dx.doi.org/10.1080/14756366.2023.2165648 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Tan, Kathrin
Jäger, Christian
Geissler, Stefanie
Schlenzig, Dagmar
Buchholz, Mirko
Ramsbeck, Daniel
Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title_full Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title_fullStr Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title_full_unstemmed Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title_short Synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
title_sort synthesis and structure–activity relationships of pyrazole-based inhibitors of meprin α and β
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870012/
https://www.ncbi.nlm.nih.gov/pubmed/36661029
http://dx.doi.org/10.1080/14756366.2023.2165648
work_keys_str_mv AT tankathrin synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb
AT jagerchristian synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb
AT geisslerstefanie synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb
AT schlenzigdagmar synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb
AT buchholzmirko synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb
AT ramsbeckdaniel synthesisandstructureactivityrelationshipsofpyrazolebasedinhibitorsofmeprinaandb